Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Oak Hill Licenses Roche’s Rugonersen,
One of the most high-profile international collaborations on tackling the coronavirus pandemic is the ACT Accelerator, a global initiative by government leaders, health organizations, businesses and p
The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer